Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders

Journal of Affective Disorders

Volumn 123, Issue 1-3, 2010, Pages 216-221

  Lee, Moon Soo ^a   Lee, Hwa Young ^a   Kang, Seung Gul ^a   Yang, Jaewon ^a   Ahn, Hyonggin ^a   Rhee, MinKyu ^b   Ko, Young Hoon ^a   Joe, Sook Haeng ^a   Jung, In Kwa ^a   Kim, Seung Hyun ^a  

^a Korea University College of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Adherence; Depressive disorder; Insight; Medication event monitoring system

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; MILNACIPRAN; MIRTAZAPINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MONITORING; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL SCALING; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PILL; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RATING SCALE; SOCIAL SUPPORT; TREATMENT OUTCOME;

ADULT; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; AWARENESS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DYSTHYMIC DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; PERSONALITY INVENTORY; REPUBLIC OF KOREA; RISK FACTORS; SOCIAL SUPPORT;

EID: 77952102563     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.10.002     Document Type: Article

References (27)

1. Amador X.F., and Gorman J.M. Psychopathologic domains and insight in schizophrenia. Psychiatr. Clin. North Am. 21 (1998) 27-42
2. Bosworth H.B., Voils C.I., Potter G.G., and Steffens D.C. The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults. Int. J. Geriatr. Psychiatry 23 (2008) 129-134
3. Byerly M., Fisher R., Whatley K., Holland R., Varghese F., Carmody T., Magouirk B., and Rush A.J. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 133 (2005) 129-133
4. Claxton A.J., Cramer J., and Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 23 (2001) 1296-1310
5. Cohen N.L., Ross E.C., Bagby R.M., Farvolden P., and Kennedy S.H. The 5-factor model of personality and antidepressant medication compliance. Can. J. Psychiatry 49 (2004) 106-113
6. Cramer J.A., and Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr. Serv. 49 (1998) 196-201
7. DiMatteo M.R. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 23 (2004) 207-218
8. Donohoe G., Owens N., O'Donnell C., Burke T., Moore L., Tobin A., and O'Callaghan E. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur. Psychiatr. 16 (2001) 293-298
9. Eker D., and Arkar H. Perceived social support: psychometric properties of the MSPSS in normal and pathological groups in a developing country. Soc. Psychiatry Psychiatr. Epidemiol. 30 (1995) 121-126
10. Ghaemi S.N., and Pope Jr. H.G. Lack of insight in psychotic and affective disorders: a review of empirical studies. Harv. Rev. Psychiatry 2 (1994) 22-33
11. Ghaemi S.N., Sachs G.S., Baldassano C.F., and Truman C.J. Insight in seasonal affective disorder. Compr. Psychiatry 38 (1997) 345-348
12. Goldberg R.W., Green-Paden L.D., Lehman A.F., and Gold J.M. Correlates of insight in serious mental illness. J. Nerv. Ment. Dis. 189 (2001) 137-145
13. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
14. Kamali M., Kelly B.D., Clarke M., Browne S., Gervin M., Kinsella A., Lane A., Larkin C., and O'Callaghan E. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur. Psychiatry 21 (2006) 29-33
15. Keller M.B., Hirschfeld R.M., Demyttenaere K., and Baldwin D.S. Optimizing outcomes in depression: focus on antidepressant compliance. Int. Clin. Psychopharmacol. 17 (2002) 265-271
16. Kemp R., Hayward P., Applewhaite G., Everitt B., and David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ 312 (1996) 345-349
17. Lin L.I. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45 (1989) 255-268
18. Lotrich F.E., and Pollock B.G. Aging and clinical pharmacology: implications for antidepressants. J. Clin. Pharmacol. 45 (2005) 1106-1122
19. Pampallona S., Bollini P., Tibaldi G., Kupelnick B., and Munizza C. Patient adherence in the treatment of depression. Br. J. Psychiatry 180 (2002) 104-109
20. Perkins D.O. Predictors of noncompliance in patients with schizophrenia. J. Clin. Psychiatry 63 (2002) 1121-1128
21. Remington G., Kwon J., Collins A., Laporte D., Mann S., and Christensen B. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr. Res. 90 (2007) 229-237
22. Rubenstein L.V., Rayburn N.R., Keeler E.B., Ford D.E., Rost K.M., and Sherbourne C.D. Predicting outcomes of primary care patients with major depression: development of a depression prognosis index. Psychiatr. Serv. 58 (2007) 1049-1056
23. Sackeim H.A., and Wegner A.Z. Attributional patterns in depression and euthymia. Arch. Gen. Psychiatry 43 (1986) 553-560
24. Sturman E.D., and Sproule B.A. Toward the development of a Mood Disorders Insight Scale: modification of Birchwood's Psychosis Insight Scale. J. Affect. Disord. 77 (2003) 21-30
25. Weiss J.J., and Gorman J.M. Antidepressant adherence and suicide risk in depressed youth. Am. J. Psychiatry 162 (2005) 1756-1757
26. Yen C.F., Chen C.C., Lee Y., Tang T.C., Ko C.H., and Yen J.Y. Insight and correlates among outpatients with depressive disorders. Compr. Psychiatry 46 (2005) 384-389
27. Zimet G.D., Powell S.S., Farley G.K., Werkman S., and Berkoff K.A. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J. Pers. Assess. 55 (1990) 610-617